In an article back in July I discussed about some of the reasons to invest in the Chinese healthcare market and mentioned five foreign healthcare companies as potential investment options. In this post lets take a quick look at four Chinese healthcare stocks that trade on the U.S. markets.
Mindray Medical International Ltd (NYSE:MR) is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products and Medical Imaging Systems.The stock is down about 12% YTD. Last year the company had a total revenue of $665 M. Mindray is experiencing strong international growth as well. In 2Q, 2010 the company's overseas sales was about $107M.
Concord Medical Services (NYSE:CCM) operates a network of radiotherapy and diagnostic imaging centers in China. At the end of last year, the Company's network comprised of 88 centers based in 57 hospitals, spanning 36 cities in China. This is a small-sized company with a market cap of about $350 M.In the second quarter the company added 11 centers bring the total number of centers to 100.
,China Medical Technologies Inc (CMED) is engaged in the commercialization, manufacture and sale of medical devices and supplies to customers primarily in China. The ADR is down 13% YTD.
China Kanghui Holdings (KH) is a developer, manufacturer and marketer of orthopedic implants in China. Kanghui offers a wide array of proprietary orthopedic implant products in trauma and spine. Since its mid-August listing, the stock has performed well. From an IPO price of $10.25 the stock price has grown to close at $18.95 Thursday. The third quarter financial results will be released on Monday, November 8, 2010, before the market opens.
Disclosure: No positions